global-regenerative-medicines-market-industry
Published

November 2016

Global Regenerative Medicines Market - Growth, Trends and Forecasts (2016 - 2021)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

The global regenerative market is estimated to reach USD 102.2 billion by 2021, from USD 24.8 billion in 2016, growing at a CAGR of 23.2 %. Small molecules and biologics show immense potential in the market and are estimated to grow at a CAGR of 18.9%.Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines which are palliative.

Global Regenerative Medicines Market- Market Dynamics

There are several factors driving and restraining the global regenerative medicines market. Some of these are listed below.

Drivers

  • Technological innovations in stem cell therapy and tissue engineering
  • Growing prevalence of bone and joint diseases
  • Growing need of orthopedic surgeries
  • Increasing awareness
  • Advancements in nanotechnology
  • Increased in innovation in stem cell therapy

Restraints

  • Rules laid down by regulatory bodies
  • Ethical issues related to regenerative medicines
  • Cost of the treatment.

The market is segmented on the basis of technology, applications, and geography.

  • By technology, the market is divided into stem cell therapy, biomaterial, and tissue engineering.
  • By type of applications, the market is segmented into bone graft substitutes, osteoarticular diseases, central nervous system and cardiovascular.
  • By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.

North America and Europe account for more than three-fourths of the revenue in 2013. However, technological advancement and research emphasis are growing in the Asia-Pacific region, so this is going to be a potential market for regenerative medicines.

Some of the key players in the market are:

  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Baxter International, Inc.
  • CONMED Corporation
  • DePuy Synthes, Inc.
  • Medtronic, Inc.

What the Report Offers

  • A wide and in-depth analysis of the market share and market size estimation based on products, applications, and services.
  • High-level analysis of the competitive landscape, which in turn includes mergers & acquisitions, collaborations, new product launches and new strategies which major players are following to keep pace with the market.
  • Market analysis for the regenerative medicine market, with region-specific assessments and competition analysis on the global and regional scale.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
RELATED REPORTS

Confused about which report to get?

Download a full report to understand our capabilities
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?